ADVFN US – Market Content Editor
-
Iran Ceasefire Extension and Strong Earnings Lift S&P 500 and Nasdaq to Fresh Records
U.S. stocks rallied on Wednesday as President Trump’s decision to indefinitely extend the ceasefire with Iran removed a key overhang that had weighed on markets the day before. The move eased fears of a return to hostilities just hours before the truce was set to expire, sending crude oil lower and giving risk appetite a…
-
Healthcare Services Group Tops Q1 Estimates as Shares Surge on Strong Results
Healthcare Services Group, Inc. (NASDAQ:HCSG) delivered a strong first-quarter performance for 2026, beating both earnings and revenue expectations and driving a sharp rally in its share price. The company reported earnings per share of $0.37, significantly above the $0.22 forecast, while revenue reached $462.8 million, modestly ahead of the $459.99 million consensus. The upbeat results…
-
Faraday Future Expands Into AI Education With U.S. Robotics Summer Camp Launch
Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) has entered the education technology space through a new partnership with U.S.-based institution Triple I, unveiling an Embodied AI (EAI) robotics summer camp aimed at students, as the company looks to broaden its “Robot & Vehicle + Education” strategy. The initiative marks the first formal collaboration for Faraday Future’s…
-
AST SpaceMobile Wins FCC Approval to Challenge Starlink Mobile
AST SpaceMobile (NASDAQ:ASTS) has secured regulatory approval in the United States to operate its satellite-to-smartphone network, positioning the company to compete directly with SpaceX’s Starlink Mobile service. The approval, granted by the Federal Communications Commission (FCC) on Tuesday, allows AST to deploy its full planned constellation of 248 satellites and provide what it describes as…
-
La Rosa Issued Nasdaq Warning Over Delayed Annual Filing
La Rosa Holdings Corp. (NASDAQ:LRHC) has received a notice from Nasdaq after failing to submit its Form 10-K annual report for the year ended December 31, 2025, the company said in a statement. The notification, dated April 16, relates to a breach of Nasdaq Listing Rule 5250(c)(1), which requires listed firms to file periodic financial…
-
Webuy Logs $3.34 Million in Bookings at Singapore Travel Expo
Webuy Global Ltd. (NASDAQ:WBUY) reported travel bookings of $3.34 million during the three-day NATAS Fair held in March 2026, marking a 27% increase from the $2.63 million recorded at the same event a year earlier, according to a company statement. The performance comes despite continued pressure on the company’s share price, which has fallen 77%…
-
Axe Compute Stock Doubles After Securing $260M AI Infrastructure Deal
Shares of Axe Compute Inc. (NASDAQ:AGPU) soared by 100% after the company revealed it had landed a $260 million enterprise infrastructure contract spanning three years, centered on a dedicated cluster of 2,304 NVIDIA B300 GPUs. The 36-month deal marks the largest contract in the company’s history and includes renewal options. It covers both high-performance GPU…
-
Wall Street Futures Point Higher as Ceasefire Extension Lifts Sentiment: Dow Jones, S&P, Nasdaq, Wall Street
U.S. stock futures are indicating a stronger open on Wednesday, with markets poised to recover after declines in the previous two sessions. The early positive tone follows news that President Donald Trump has extended the U.S. ceasefire with Iran, prompting renewed buying interest. Describing Iran’s leadership as “seriously fractured,” Trump said in a Truth Social…
-
Gold Edges Higher as Dollar Weakens Following Iran Ceasefire Extension
Gold prices moved modestly higher on Wednesday, supported by a softer U.S. dollar, after President Donald Trump announced an extension of the ceasefire agreement with Iran, raising cautious expectations of a longer period of stability in the Middle East. As of 06:07 ET (10:07 GMT), spot gold was up 0.7% at $4,750.76 per ounce, while…
-
Johnson & Johnson’s IMAAVY Demonstrates Durable Disease Control in Myasthenia Gravis
Johnson & Johnson (NYSE:JNJ) has reported new data from its Phase 3 Vivacity-MG3 trial showing that its therapy IMAAVY (nipocalimab-aahu) sustained disease control in adults with generalized myasthenia gravis over a follow-up period of up to 120 weeks. The study followed 153 patients who tested positive for disease-related antibodies, including anti-AChR and anti-MuSK. At the…